Stem Cell Research & Therapy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2024-01-02 加油！来自江苏省

偏重的研究方向：干细胞
经验分享：记录一下，怂怂怂
Submitted to Journal: 12 Dec 2023
Editor Assigned: 13 Dec 2023
Under Review: 25 Dec 2023
Reviews Completed: 31 Dec 2023

18 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2023-07-09 Zhudingding 来自北京

2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2024-02-09 ms4000002111139793 来自山西省

偏重的研究方向：干细胞;干细胞治疗
经验分享：想知道投的这个杂志的综述容易接收吗

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2023-06-14 ms8000000826346257 来自山西省

投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录...

49 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2023-11-15 starter2009 来自北京

投稿当天Editor Assigned，已经半个月了

26 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2021-05-10 krygios

偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration
经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒

108 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2023-03-27 Faith Mary 来自四川省

二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？

37 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2023-06-15 ms2000000073569811 来自上海

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：干细胞
经验分享：慎重投稿！！！！！！！

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2023-02-25 146eb46fm56暂无昵称来自江苏省

偏重的研究方向：免疫调控
经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化

47 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116444, encodeId=916f21164449a, content=偏重的研究方向：免疫调控 经验分享：请问editor assigned 需要多久啊，已经快2月了没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/2b3518894b7443769a3c33c6d1dfb17a/9438e388616e46dfa54e355d1ae1fe7d.jpg, createdBy=27495176994, createdName=146eb46fm56暂无昵称, createdTime=Sat Feb 25 18:55:27 CST 2023, time=2023-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051921, encodeId=60db10519217f, content=大家有没有文章接收后编辑索要原始数据的情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 16 12:17:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]

2021-09-16 ms4000001710795128

大家有没有文章接收后编辑索要原始数据的情况

133 35

展开35条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务